Botanical supplements derived from grapes are functional in animal model systems for the amelioration of neurological conditions, including cognitive impairment. Rats fed with grape extracts accumulate 3'--methyl-quercetin-3--β-d-glucuronide () in their brains, suggesting as a potential therapeutic agent. To develop methods for the synthesis of and the related 4'--methyl-quercetin-7--β-d-glucuronide (), 3--methyl-quercetin-3'--β-d-glucuronide (), and 4'--methyl-quercetin-3'--β-d-glucuronide (), which are not found in the brain, we have evaluated both enzymatic semisynthesis and full chemical synthetic approaches. Biocatalysis by mammalian UDP-glucuronosyltransferases generated multiple glucuronidated products from 4'--methylquercetin, and is not cost-effective. Chemical synthetic methods, on the other hand, provided good results; , , and were obtained in six steps at 12, 18, and 30% overall yield, respectively, while was synthesized in five steps at 34% overall yield. A mechanistic study on the unexpected regioselectivity observed in the quercetin glucuronide synthetic steps is also presented.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136248 | PMC |
http://dx.doi.org/10.1021/acs.jafc.0c04500 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!